Endocrine Society, European Society of Endocrinology Partner to Produce Practice Protocols

The Endocrine Society and the European Society of Endocrinology (ESE) have reached an historic agreement to jointly develop Clinical Practice Guidelines providing evidence-based recommendations for clinical care and practice. 

Endocrine Society President Gary D. Hammer, MD, PhD, and European Society of Endocrinology President Andrea Giustina, MD, signed the agreement during the 22nd European Congress of Endocrinology’s opening ceremony, held virtually on Saturday, Sept. 5. 

 “This historic collaboration between the Endocrine Society and the European Society of Endocrinology is an important step to provide a unified global voice and to increase the reach and relevance of Clinical Practice Guidelines.” – Gary D. Hammer, MD, PhD, President, Endocrine Society

Developing globally relevant guidelines will support the delivery of up-to-date care to patients worldwide. The joint Clinical Practice Guideline program also will recognize global differences in access to diagnostic tools and therapies.   

This historic collaboration between the Endocrine Society and the European Society of Endocrinology is an important step to provide a unified global voice and to increase the reach and relevance of Clinical Practice Guidelines,” Hammer said. “ESE shares our robust approach to researching and vetting guidelines, and our organizations are proud to serve as international leaders in this groundbreaking effort.” 

 Jointly developed guidelines will help ensure clinicians who treat endocrine conditions such as diabetes, obesity, osteoporosis, thyroid, and adrenal conditions together with hormone-related cancers will have access to a consistent, timely set of patient care recommendations. The unified guidelines will help health care providers provide better patient care, improve health care outcomes, increase patient safety and control health care costs. 

“We are very pleased to be working with our friends at the Endocrine Society to develop the Guidelines,” Giustina says. This is perfectly aligned with the vision of my presidency, which is inclusion and putting the patient at the heart of everything we do. I feel sure this is the start of something great and an historical step towards the creation of a strong global endocrine community.” 

This collaboration will kick off with the development of two inaugural guidelines: Diabetes in Pregnancyled by the Endocrine Society, and Management of Corticosteroid Therapy, led by the European Society of Endocrinology. 

For more information on our Clinical Practice Guidelines, visit https://www.endocrine.org/clinical-practice-guidelines and https://www.ese-hormones.org/publications/guidelines/ 

You may also like

  • Endocrine Society Endorses Bipartisan Bill to Address Insulin Affordability 

    INSULIN Act would expand insulin co-pay cap to commercial market and encourage competition. The Endocrine Society today endorsed the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, a bipartisan bill to address insulin affordability introduced by Sens. Jeanne Shaheen (D-NH), Susan Collins (R-ME), Raphael Warnock (D-GA), and John Kennedy (R-LA).   This historic legislation would cap out-of-pocket insulin costs at $35 per month for people on private insurance, protecting access to this life-saving medication for millions of people with diabetes. The legislation also would create a program to…

  • In Memoriam: Martin Savage 1941-2026

    Martin O. Savage, Emeritus Professor of Pediatric Endocrinology, William Harvey Research Institute, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, passed away on February 24, 2026. Martin Savage was a kind, generous, quietly spoken man, an inspirational pediatrician and an internationally renowned clinician scientist. He was passionate about teaching…

Find more in